President Bill Clinton announced today that his foundation has negotiated new agreements to lower the price of HIV/AIDS treatment for children. Cipla and Ranbaxy will price a new child-friendly product...for less than $60 per year... The new prices will be available to the foundation’s Procurement Consortium, which currently includes 62 developing countries in Africa, Asia, Latin America and the Caribbean, together representing more than 90 percent of people living with HIV/AIDS in developing countries. [also refers to Abbott Laboratories, Aurobindo Pharmaceuticals, Bristol-Myers Squibb, Merck, Roche]